RxDoctor Payments Data

Rachel Richardson

Psychiatric/Mental Health · Summersville, WVNPI 1609401520

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.1% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,532 and has fallen 61.0% since, to $597 in 2023.

$3,049in general payments, 2019–2025

Across 211 payments — averaging $14.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$606
  • AbbVie$524
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$278
  • Sunovion Pharmaceuticals Inc.$263
  • Alkermes, Inc.$259
  • Johnson & Johnson$238
  • plus $881 from 9 others

What the payments were for

  • Food & beverage$2,96097%
  • Education$893%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,049 in reported general payments places this provider in the 85th percentile of 142 psychiatric/mental health providers in West Virginia.

See all psychiatric/mental health providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
SuboxoneBuprenorphine Hcl/Naloxone Hcl33$5,036
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl39$1,399
Trazodone Hcl27$261
Quetiapine Fumarate24$251
Duloxetine Hcl27$221
Olanzapine14$176
Risperidone19$172
Buspirone Hcl24$162
Lamotrigine21$152
Fluoxetine Hcl18$129
Mirtazapine12$85
Sertraline Hcl15$58

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Indivior Inc.Suboxone$94$5,03633 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 142 psychiatric/mental health providers in West Virginia.

Other psychiatric/mental health in Summersville

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →